IT
Ingenia Therapeutics Inc. Stock: price and insider trades · South Korea
인제니아테라퓨틱스
Ingenia Therapeutics Inc.: what insiders have been doing
Insider filings for Ingenia Therapeutics Inc. are scarce in the DART (FSS) feed. This page will fill in as new trades are disclosed. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.
Insider Decl.
n/a
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Financial data
· cache
₩22,100
Analyst consensus
Income statement
EBITDA-₩24.3B
Balance sheet & cash
Market cap₩1.1T
Debt / Equity10%
Profitability & ownership
% institutions0.2%
Declarations9 total
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- Other0DART
9 of 9 declarations
About Ingenia Therapeutics Inc.
Ingenia Therapeutics is a company listed on the XKRX market, specializing in the development of innovative therapies. It focuses on research and the development of therapeutic solutions for various diseases.
